🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

As we gather this Thanksgiving, we’re grateful for the innovation, resilience, and passion of those who drive forward our work every day. Thank you to our team, partners, and community for making our work possible. Wishing you and your loved ones a safe and joyful holiday season

🌴In Coral Gables today for the 7th Annual Evercore HealthCONx Conference? Don’t miss our co-founder and CEO Dr. Stephen Uden’s fireside chat Wednesday, December 4th at 12:30 p.m. ET. Listen live to today’s webcast: wsw.com/webcast/everco…

Our CFO Jon Lieber proudly represented Rallybio at last night's #Fierce50 Gala, where we were an Innovation honoree! 🥂 We have much to look forward to next year and are another step closer to transforming lives. Thank you, FiercePharma! #RareDisease fiercepharma.com/pharma/rallybio

Were you able to make it to ASH this year? If so, you may have seen some exciting new data from the Rallybio pipeline shared throughout the weekend on RLYB212 and RLYB332! Check out both posters on our site here: rallybio.com/publications-p…

It was great to see our colleagues Mark Ma and Amanda Hayward, along with many of our partners including Huiying Zhi from Versiti, at the ASH conference earlier this week to share exciting data from our RLYB212 and RLYB332 programs!

The FDA’s updated Women’s Health Research Roadmap advances research and safety for FDA-regulated products for women.

As we work to improve maternal and fetal health outcomes, we're inspired by this year’s roadmap on biomarker science, clinical study design, and data analysis, fostering collaboration and innovation in maternal care. Read more here: fda.gov/consumers/abou… #WomensHealth

2025 is the year to advance maternal and neonatal health. Meet our team in San Francisco next week to learn about our mission to eradicate #FNAIT, a rare and potentially life-threatening disease  #JPM25 #JPM2025

This January, we’re raising awareness for #BirthDefectsAwarenessMonth and advancing solutions for maternal and fetal health. Learn more from organizations like the NBDPN.

Thanks to Eleanor Malone and Scrip, Citeline Commercial for including our Founder & Chairman Martin Mackay’s thoughts on Eroom’s law & how the FDA can plan for an influx of pending drug submissions in this piece on what’s to come for biopharma in 2025! insights.citeline.com/scrip/scrip-as…

#MaternalHealthAwaresnessDay we reflect on how Rh disease is nearly eradicated thanks to innovation & early detection. At Rallybio, we're working to do the same for FNAIT. Together, we can transform #maternalhealth with better testing & treatments. #RLYB116

Rallybio has dosed the first participant in the RLYB212 Ph2 clinical trial in pregnant women at higher risk for HPA-1a alloimmunization and FNAIT. Key data readouts from the sentinel participant are expected in 2Q 2025 and 3Q 2025. #RareDisease #RLYB212 #Rallybio $RLYB

This morning Rallybio announced our fourth quarter and full year 2024 financial results and business updates. Read our press release: bit.ly/4hxoqvq #Rallybio #RLYB #biotech #earnings